Search results for: IgG2b
#32058991 // Save this To Up
Biological risk assessment of miltefosine in concomitant infection with opportunistic toxoplasmosis.Although miltefosine is the first line for treatment of leishmaniasis, it could have multiple un-recognized effects if any infection accidentally takes place during therapy. The aim is to precisely evaluate the molecular and biochemical remarks of miltefosine on Toxoplasma gondii accidental infection during miltefosine therapeutic course.
1259 related Products with: Biological risk assessment of miltefosine in concomitant infection with opportunistic toxoplasmosis.Liver cancer tissue array Infection diseases: Heli Hepatocellular carcinoma Syringe pump can be contr Liver tissue cancer tissu Infection diseases: Heli RANK Ligand Soluble, Huma Pro Insulin FGF1 & FGFR4 Protein Prot Multiple organ cancer fro ELISA Rat , Interleukin-2 Mouse AntiSerratia marces
#32057430 // Save this To Up
The reduction in the immunoglobulin G and immunoglobulin E binding capacity of β-lactoglobulin via spray-drying technology.Bovine β-lactoglobulin (β-LG) is the major allergen in milk powder. The IgG/IgE binding capacity and structural characteristics of β-LG after spray drying in the presence or absence of α-lactose at 120 and 180°C were investigated by ELISA and mass spectrometry. At a drying temperature of 120°C, no change was found in the IgG/IgE binding capacity of β-LG and no change was observed in free amino group content, fluorescence intensity, or detectable glycation. At a drying temperature of 180°C, aggregation of β-LG occurred, leading to a decrease in the IgG/IgE binding capacity. When α-lactose was also present, 7 lysine side-chains in β-LG were modified by glycation and the IgG/IgE binding capacity was further decreased. Therefore, the glycation and structural changes in β-LG were responsible for the reduction in the IgG/IgE binding capacity during high temperature (180°C) spray drying.
1183 related Products with: The reduction in the immunoglobulin G and immunoglobulin E binding capacity of β-lactoglobulin via spray-drying technology.MultiGene Gradient therm Multiple organ tumor tiss Mouse Insulin-like Growth Goat Anti-Human ERN1 IRE1 3 pairs of specific siRNA Rat intestinal fatty acid Head & Neck cancer test t Goat Anti-Human EPB41L2 4 Esophagus squamous cell c Thermostable TDG Enzyme & Endometrium cancer test t Middle advanced stage eso
#32057333 // Save this To Up
Measles antibody levels among vaccinated and unvaccinated children 6-59 months of age in the Democratic Republic of the Congo, 2013-2014.Measles is endemic in the Democratic Republic of the Congo (DRC), and 89-94% herd immunity is required to halt its transmission. Much of the World Health Organization African Region, including the DRC, has vaccination coverage below the 95% level required to eliminate measles, heightening concern of inadequate measles immunity.
1349 related Products with: Measles antibody levels among vaccinated and unvaccinated children 6-59 months of age in the Democratic Republic of the Congo, 2013-2014.FDA Standard Frozen Tissu FDA Standard Frozen Tissu FDA Standard Frozen Tissu FDA Standard Frozen Tissu FDA Standard Frozen Tissu FDA Standard Frozen Tissu MultiGene Gradient therm Thermal Shaker with cooli Normal rat multiple organ Anti 3 DG imidazolone Mon Normal rat multiple organ FDA Standard Frozen Tissu
#32053412 // Save this To Up
Affinity of Streptococcal G Protein to Forest Musk Deer () Serum Immunoglobulin G.Forest musk deer (FMD; ) immunoglobulin G efficiently bound to streptococcal G protein (SPG) and weakly bound to staphylococcal A protein. The results suggested that horseradish peroxidase-conjugated SPG could be chosen as an enzyme-labeled antibody substitute and laid a foundation for immunologic research in FMD disease.
2588 related Products with: Affinity of Streptococcal G Protein to Forest Musk Deer () Serum Immunoglobulin G.Human Dnak (HSP70) His ta Glycated Serum Protein (F Native Pregnant Mare Seru Toxoplasma gondii GRA8, r Leucine-Rich Alpha-2-Glyc Zinc-Alpha-2-Glycoprotein DIABETIC DISEASES-Glycate Native Pregnant Mare Seru DIABETIC DISEASES Glycate Native Pregnant Mare Seru Recombinant Human Galecti Recombinant HCV NS3 Genot
#32053192 // Save this To Up
Interference of M-protein on Thrombin Time Test: A Case Report.A case of interference of monoclonal protein (M-protein) on thrombin time (TT) test in a 39-year-old Caucasian male patient is presented.
Embryonal tumor test tiss Brain cancer test tissue Stomach cancer test tissu Lymphoma test tissue arra FDA normal and tumor orga Lung cancer test tissue a Penis cancer test tissue Pancreatic cancer test ti Non-small cell lung cance Oral cavity tumor test ti Kidney cancer test tissue Malignant melanoma test t
#32048894 // Save this To Up
Immunogenicity and safety after the third vaccination with the 23-valent pneumococcal polysaccharide vaccine in elderly patients with chronic lung disease.An observational study to assess immunogenicity before and after the first, second, and third vaccinations with the 23-valent pneumococcal polysaccharide vaccine in a cohort of 16 elderly patients with chronic lung diseases was conducted. The safety of this vaccine was also compared between the first, second, and third vaccinations. Serotype-specific immunoglobulin G (IgG) and the opsonization index (OI) for serotypes 6B, 14, 19F, and 23F were analyzed, and adverse local and systemic reactions were compared. The levels of serotype-specific IgG and OI increased significantly 1 month after the first, second, and third vaccinations. Peak IgG levels were higher after the third vaccination than after the second vaccination, but the levels of serotypes 6B, 14, and 19F were not higher than after the first vaccination. Serotype-specific OIs did not differ after the third vaccination compared with the first and second vaccinations. The level of serotype-specific IgG required for killing 50% of bacteria decreased significantly 1 month after the second vaccination. This level was slightly elevated immediately before the third vaccination but decreased after the third vaccination. Although self-limited local and systemic reactions were more frequent after the second and third vaccinations than after the first vaccination, no serious systemic reactions were seen after any vaccination. These data suggest that sustained functional serotype-specific IgG is produced after the first, second, and third vaccinations and they confirm the safety of the second and third vaccinations in elderly people with chronic lung disease.
1912 related Products with: Immunogenicity and safety after the third vaccination with the 23-valent pneumococcal polysaccharide vaccine in elderly patients with chronic lung disease.Lung disease spectrum tis FDA Standard Frozen Tissu Thermal Shaker with cooli Lung disease spectrum tis FDA Standard Frozen Tissu FDA Standard Frozen Tissu FDA Standard Frozen Tissu Lung disease spectrum tis FDA Standard Frozen Tissu Syringe pump can be contr FDA Standard Frozen Tissu Anti 3 DG imidazolone Mon
Voortstraat 49, 1910 Kampenhout BELGIUM
Tel 0032 16 58 90 45 Fax 0032 16 50 90 45
9, rue Lagrange, 75005 Paris
Tel 01 43 25 01 50 Fax 01 43 25 01 60
52062 Aachen Deutschland
Tel 0241 40 08 90 86 Fax 0241 55 91 05 36
Howard Frank Turnberry House
1404-1410 High Road
Whetstone London N20 9BH
Tel 020 3393 8531 Fax 020 8445 9411
Schweiz Züri +41435006251
Česká republika Praha +420246019719
Ireland Dublin +35316526556
Norge Oslo +4721031366
Finland Helsset +358942419041
Sverige Stockholm +46852503438
Ελλάς Αθήνα +302111768494
Magyarország Budapest +3619980547
GENTAUR Poland Sp. z o.o.
ul. Grunwaldzka 88/A m.2
81-771 Sopot, Poland
Tel 058 710 33 44
Fax 058 710 33 48
GENTAUR Nederland BV
5521 DG Eersel Nederland
Tel 0208-080893 Fax 0497-517897
Piazza Giacomo Matteotti, 6, 24122 Bergamo
Tel 02 36 00 65 93 Fax 02 36 00 65 94
53 Iskar Str. 1191 Kokalyane, Sofia